Since the activity of several conventional anticancer drugs is restricted by resistance mechanisms and dose-limiting side-effects, the design of formulations for local application on malignant lesions seems to be an efficient and promising
drug delivery approach. In this study, the effect of locally applied
5-FU on cell death was evaluated both in a SCC4/HEK001 model and in a newly proposed 3D outgrowth model of
oral squamous cell carcinoma (OSCC). Initially, the optimal
drug dose was established by delivery of solutions containing different amounts of
5-FU. The
solution containing 1% (w/v) of
5-FU resulted effective in inducing cell death with complete eradication of cell colonies. Buccal
tablets were designed to deliver
5-FU locoregionally to the
cancer lesions of the oral cavity.
Tablets were prepared using a
drug loaded matrix of acrylic/
methacrylic acid copolymer containing 1% (w/w) of
5-FU and applied on 3D outgrowths. The drug release from
tablets appeared to be sufficient to induce cell death as confirmed by transmission electron microscopy and enzymatic assay (TUNEL). After 120 h of treatment, when about 90% of the
drug had been discharged from the
tablets into the culture environment,
5-FU caused loss of cell-cell communications and apoptotic cell death. After 192 h, a complete disaggregation of the 3D oral outgrowths and the death of all the cells was observed. Buccal matrix
tablets could be considered a promising new approach to the locoregional treatment of OSCC. Risks of systemic toxicity are avoided since very low
drug doses are delivered.